Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue: +38.3%
EPS: −294.7%
Free cash flow: +5.09%
Total debt: +40.8%

Quarter to June 2026, against a year earlier

24.11 2.55 −9.56%

Follow HIMS

Alert me

Market cap: $5.6B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 4/9
Altman Z: 4.10
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Hims & Hers Health, Inc. (HIMS) trades at a P/S ratio of 2.2×. Over the past ten years it has ranged from 0.0× (December 2020) to 13.7× (June 2021); the current reading is higher than 27% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 2.1× and below the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HIMS/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Hims &amp; Hers Health, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HIMS/metrics/ps-ratio">Hims &amp; Hers Health, Inc. (HIMS) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	3.1×	(12.02%)
FY2024	3.5×	52.80%
FY2023	2.3×	(5.65%)
FY2022	2.5×	(47.10%)
FY2022	4.6×	3.05%
FY2021	4.5×	20.75%
FY2021	3.7×	7.40%
FY2020	3.5×	—
FY2020	0.0×	—
FY2019	0.0×	—

Period	P/S ratio	Change
Jun 2026	3.1×	55.79%
Mar 2026	2.0×	(35.70%)
Dec 2025	3.1×	(46.42%)
Sep 2025	5.8×	4.53%
22 more quarters	Free account

Against its own ten years

Low 0.0× High 13.7×

Ten-year median 3.1×

Current reading's percentile 11

Company	P/S ratio
AMRX AMNEAL PHARMACEUTICALS, INC. compare	2.0×
HIMS Hims & Hers Health, Inc.	2.2×
SUPN Indivior Pharmaceuticals Inc. compare	2.4×
RDY Dr. Reddy's Laboratories Ltd compare	3.6×
LNTH Lantheus Holdings, Inc. compare	4.2×
ALKS Alkermes plc compare	4.3×
KNSA Kiniksa Pharmaceuticals International, plc compare	7.3×
LQDA Liquidia Corporation compare	8.8×
AMLX Amylyx Pharmaceuticals, Inc. compare	35.4×
Drug Manufacturers Specialty & Generic industry median	2.1×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Hims & Hers Health, Inc. (HIMS) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on HIMS

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on HIMS

Stockrow Weekly